NCT02597829Unknown4 期
Does Clinical Response Correlate With Serum Certolizumab Levels? A Prospective Open Label Trial of Adult Patients With Active Crohn's Disease (APOLLO)
Shafran Gastroenterology Center1 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2015年11月最近更新:
适应症
干预措施
相关药物
试验速览
- 阶段
- 4 期
- 发起方
- 入组人数
- 20
- 试验地点
- 1
- 主要终点
- Proportion of subjects who achieve endoscopic improvement.
研究概览
简要总结
A prospective open label trial of adult patients with active Crohn's disease to determine if plasma concentrations of certolizumab pegol correlate to mucosal healing.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 70 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
研究组 & 干预措施
Open Label Certolizumab Pegol
Other
Active Treatment
干预措施: Certolizumab Pegol (Drug)
结局指标
主要结局
Proportion of subjects who achieve endoscopic improvement.
时间窗: 20 Weeks
次要结局
- Proportion of subjects who achieve clinical response.(20 Weeks)
- Proportion of subjects who achieve clinical remission.(20 Weeks)
研究者
研究点 (1)
Loading locations...
相似试验
终止
3 期
Assessment of Mucosal Activity to Improve the Prognosis of Patients With Crohn's Disease Treated With ImmunosuppressantsMucosal InflammationCrohn's DiseaseNCT01562951Grupo Espanol de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa15
Unknown
4 期
Optimizing Cimzia in Crohn's PatientsCrohn's DiseaseNCT01024647Atlanta Gastroenterology Associates50
Unknown
不适用
Chromoendoscopy for Dysplasia Detection in Chronic Inflammatory Bowel DiseaseCrohn's ColitisUlcerative ColitisNCT01505842Karolinska University Hospital304
撤回
3 期
A Trial Evaluating Safety of Chronic Therapy With Certolizumab Pegol in Crohn's DiseaseCrohn's DiseaseNCT00358683UCB Pharma
已完成
3 期
Evaluation of Topical 10% Metronidazole Ointment for the Treatment of Active Perianal Crohn's DiseaseCrohn's DiseaseNCT00509639S.L.A. Pharma AG74